Spherics, Inc. (Spherics) is engaged in designing and marketing of oral drug delivery technologies. The company specializes in providing oral products in the area of neurology. The product portfolio of the company includes: oral drug delivery technologies.
The oral drug delivery systems improve drug performance by increasing absorption and residence time in specific regions of the gastrointestinal tract. Phase Inversion Nanotechnology (PIN) enables oral and non-oral delivery of biologics, poorly soluble drugs and/or drugs with low permeability.
These technologies expand the therapeutic benefits of drugs that otherwise do not remain at the target absorptive site long enough to be effective. This procedure of drug delivery at the at the targeted gastro-intestinal absorptive sites extends the therapeutic nature of a variety of drugs.
The company is also into R&D. The company is headquartered in Massachusetts, United States.